Dr Elizabeth Plimack talks to ecancer in an online interview for the ASCO virtual meeting 2020 about the KEYNOTE-426 study.
She outlines the trial design and explains the ongoing development of the study.
Dr Plimack discusses the updated results and maintained benefit of this combination.